ABCL vs. QLD
Compare and contrast key facts about AbCellera Biologics Inc. (ABCL) and ProShares Ultra QQQ (QLD).
QLD is a passively managed fund by ProShares that tracks the performance of the NASDAQ-100 Index (200%). It was launched on Jun 21, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABCL or QLD.
Key characteristics
| ABCL | QLD | |
|---|---|---|
| YTD Return | -54.12% | 33.89% |
| 1Y Return | -40.45% | 63.21% |
| 3Y Return (Ann) | -44.83% | 9.89% |
| Sharpe Ratio | -0.70 | 1.77 |
| Sortino Ratio | -0.87 | 2.25 |
| Omega Ratio | 0.91 | 1.30 |
| Calmar Ratio | -0.40 | 1.51 |
| Martin Ratio | -1.07 | 7.73 |
| Ulcer Index | 36.17% | 8.03% |
| Daily Std Dev | 55.21% | 35.17% |
| Max Drawdown | -95.94% | -83.13% |
| Current Drawdown | -95.55% | -7.51% |
Correlation
The correlation between ABCL and QLD is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ABCL vs. QLD - Performance Comparison
In the year-to-date period, ABCL achieves a -54.12% return, which is significantly lower than QLD's 33.89% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABCL vs. QLD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and ProShares Ultra QQQ (QLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABCL vs. QLD - Dividend Comparison
ABCL has not paid dividends to shareholders, while QLD's dividend yield for the trailing twelve months is around 0.29%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABCL AbCellera Biologics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QLD ProShares Ultra QQQ | 0.29% | 0.33% | 0.31% | 0.00% | 0.00% | 0.13% | 0.06% | 0.02% | 0.90% | 0.11% | 0.19% | 0.13% |
Drawdowns
ABCL vs. QLD - Drawdown Comparison
The maximum ABCL drawdown since its inception was -95.94%, which is greater than QLD's maximum drawdown of -83.13%. Use the drawdown chart below to compare losses from any high point for ABCL and QLD. For additional features, visit the drawdowns tool.
Volatility
ABCL vs. QLD - Volatility Comparison
AbCellera Biologics Inc. (ABCL) has a higher volatility of 13.52% compared to ProShares Ultra QQQ (QLD) at 8.51%. This indicates that ABCL's price experiences larger fluctuations and is considered to be riskier than QLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.